Fimaporfin (TPCS2a) is an endosomal/lysosomal-localizing photosensitizer[1].
The endosomal/lysosomal localizing photosensitizer Fimaporfin (0.35 µg/ml) is used in the drug delivery technology photochemical internalization (PCI) in combination with drugs that usually are trapped in endosomes and/or lysosomes[1].
References:
[1]. Kaja Lund, et al. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin. J Exp Clin Cancer Res. 2017 Dec 19;36(1):187.
















